| Name |
Carfilzomib, Free Base
|
| Supplier |
Biorbyt
|
| Catalog |
orb153608
|
| Prices |
$272.00, $315.00, $349.00, $391.00, $510.00, $740.00
|
| Sizes |
5 mg, 10 mg, 50 mg, 25 mg, 100 mg, 200 mg
|
| Cas Number |
[868540-17-4]
|
| Pubchem |
11556711
|
| Chemical Name |
(2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide
|
| Formula |
C40H57N5O7
|
| Molecular Weight |
719.91 g/mol
|
| Purity |
>99% pure
|
| Description |
Carfilzomib, also known as PR-171, is an irreversible, epoxomicin-related proteasome inhibitor. Carfilzomib is a second-generation proteasome inhibitor that is being investigated as a potential treatment for patients with multiple myeloma and solid tumors. It is being studied in several clinical trials either as a single-agent or in combination with other therapies.
|
| Supplier Page |
Shop
|
